TAP Consulting’s PetMed Express PETS Stock Holding History

TAP Consulting’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	–	–	423
2021 Q4	$0	Buy	+5	New	+$138	﹤0.01%	577

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

TAP Consulting's PETS Position: Q1 2022 in Review

TAP Consulting sold out of PetMed Express (PETS) in Q1 2022, closing a stake of 5 shares.

TAP Consulting first reported a position in PETS in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 180 funds tracked by Wall St. Rank hold PETS as of Q1 2022.

TAP Consulting reported no remaining PetMed Express position as of Q1 2022 after selling out during the quarter.
TAP Consulting sold 5 PetMed Express shares in Q1 2022.
TAP Consulting first reported a position in PetMed Express in Q4 2021 and held it in 1 quarter.
TAP Consulting's PetMed Express position peaked at $0 in Q4 2021.
180 funds tracked by Wall St. Rank held PetMed Express as of Q1 2022.

Based on TAP Consulting's 13F filing for Q1 2022, filed 26 Apr 2022.